Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2487-2503
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2487
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2487
Table 3 Relationship between density of infiltrating immune cells and clinico-pathological features
Features | IT CD3 | P value | ST CD3 | P value | IT CD8 | P value | ST CD8 | P value | IT CD163 | P value |
Median | > 58 | > 95 | > 70 | > 68 | > 240 | |||||
Age | 0.714 | 0.275 | 0.026 | 0.224 | 0.162 | |||||
< 60 | 73 | 47 | 42.1 | 32.9 | 7.4 | |||||
≥ 60 | 71.5 | 52.8 | 52.7 | 39.3 | 13.5 | |||||
Sex | 0.039 | 0.557 | 0.814 | 0.699 | 0.354 | |||||
Female | 76.5 | 52 | 48.4 | 37.7 | 8.7 | |||||
Male | 67.8 | 49 | 47.3 | 35.7 | 12.7 | |||||
Gastric region location | 0.503 | 0.585 | 0.795 | 0.901 | 0.031 | |||||
No antrum | 74.1 | 52.4 | 48.7 | 36.2 | 16.7 | |||||
Antrum | 71.1 | 49.4 | 47.4 | 36.9 | 7.1 | |||||
Bormann | 0.648 | 0.441 | 0.338 | 0.006 | 0.462 | |||||
I-II | 70.4 | 47.4 | 41.8 | 22.6 | 5.3 | |||||
III | 73.6 | 55.6 | 50.7 | 43 | 11.7 | |||||
IV-V | 68.9 | 52.9 | 46.1 | 30 | 13 | |||||
Lauren histology | 0.03 | 0.003 | 0.308 | 0.003 | 0.038 | |||||
Intestinal | 66.2 | 57.4 | 43.7 | 40.3 | 8.2 | |||||
Diffuse | 78 | 36.6 | 50 | 22.2 | 17.8 | |||||
Mixed | 75.9 | 50.8 | 52.7 | 46.3 | 2.9 | |||||
Grade | <0.001 | 0.311 | <0.001 | 0.083 | 0.02 | |||||
1 | 59 | 55.3 | 26.8 | 20.5 | 3.8 | |||||
2 | 62.9 | 54.2 | 40.7 | 38.2 | 4.3 | |||||
3 | 79.5 | 46.4 | 55.3 | 39.2 | 16.4 | |||||
Lymphovascular invasion | 0.602 | 0.241 | 0.092 | 0.117 | 0.865 | |||||
No | 73.9 | 55.2 | 41.8 | 30.4 | 11.3 | |||||
Yes | 71.5 | 48.4 | 50.5 | 39.3 | 10.5 | |||||
Lymph node involvement | 0.723 | 0.983 | 0.487 | 0.141 | 0.252 | |||||
Yes | 72.6 | 50.4 | 48.9 | 39.1 | 12.1 | |||||
No | 71 | 50.5 | 45.2 | 30.6 | 6.3 | |||||
Pathology stage | 0.942 | 0.101 | 0.674 | 0.058 | 0.197 | |||||
I | 70.9 | 50 | 42.9 | 20 | 9.5 | |||||
II | 73.2 | 59 | 47.2 | 41 | 4.1 | |||||
III | 72 | 46.3 | 49.2 | 37.8 | 13.3 | |||||
Recurrence | 0.02 | 0.079 | 0.448 | 0.475 | 0.389 | |||||
No | 76 | 53.9 | 46.6 | 35.2 | 9.3 | |||||
Yes | 65.9 | 44.4 | 50 | 39.1 | 13.2 | |||||
H. pylori HE | 0.547 | 0.817 | 0.356 | 0.97 | 0.637 | |||||
Absent | 71.1 | 51.4 | 49.1 | 36 | 13.4 | |||||
Present | 73.9 | 52.8 | 44.2 | 36.2 | 11.1 | |||||
H. pylori qPCR | 0.143 | 0.335 | 0.001 | 0.001 | 0.105 | |||||
Absent | 83.1 | 55.9 | 62.7 | 49.1 | 26.1 | |||||
Present | 74 | 48.1 | 37 | 22.8 | 14.1 | |||||
CagA/H. pylori+ | 0.254 | 0.603 | 0.023 | 0.54 | 0.729 | |||||
CagA- | 82.9 | 42.9 | 57.5 | 21.2 | 14.3 | |||||
CagA+ | 74.2 | 48 | 37.2 | 26.6 | 17.2 | |||||
VacAs/H. pylori+ | 0.992 | 0.843 | 0.071 | 0.855 | 0.823 | |||||
VacAs- | 76.8 | 45.8 | 51.7 | 24.4 | 15.2 | |||||
VacAs+ | 76.9 | 47.6 | 37.3 | 25.9 | 16.9 | |||||
VacAs1/H. pylori+ | 0.397 | 0.432 | 0.942 | 0.234 | 0.543 | |||||
VacAs1- | 79.2 | 53.5 | 36.4 | 18.4 | 14.7 | |||||
VacAs1+ | 72.2 | 44.7 | 37 | 30 | 20.8 | |||||
VacAm/H. pylori+ | 0.1 | 0.248 | 0.255 | 0.884 | 0.865 | |||||
VacAm- | 69.4 | 40.4 | 47.6 | 24.5 | 17.1 | |||||
VacAm+ | 80.6 | 50.6 | 38.7 | 25.6 | 15.8 | |||||
VacAm1/H. pylori+ | 0.145 | 0.098 | 0.242 | 0.822 | 0.877 | |||||
VacAm1- | 89.7 | 65.2 | 48.1 | 23.8 | 16.7 | |||||
VacAm1+ | 77 | 44.8 | 35.4 | 26.3 | 15.2 | |||||
VacAs1+m1+/H. pylori+ | 0.113 | 0.289 | 0.913 | 0.253 | 0.345 | |||||
No VacAs1+m1+ | 86 | 57.5 | 37.7 | 21.6 | 12.9 | |||||
VacAs1+m1+ | 72.2 | 44 | 38.9 | 34.6 | 23.5 | |||||
dMMR | 0.393 | 0.049 | 0.095 | 0.05 | 0.169 | |||||
No | 75.4 | 47.6 | 45.5 | 32.3 | 11.5 | |||||
Yes | 71.3 | 59.5 | 54.7 | 43.9 | 5.1 | |||||
HER2 status | 0.06 | 0.204 | 0.009 | 0.404 | 0.835 | |||||
Negative | 74.4 | 52.4 | 49.9 | 37.7 | 11.1 | |||||
Positive | 56.5 | 38.1 | 21.7 | 28.6 | 9.1 |
- Citation: Castaneda CA, Castillo M, Bernabe LA, Sanchez J, Fassan M, Tello K, Wistuba II, Chavez Passiuri I, Ruiz E, Sanchez J, Barreda F, Valdivia D, Bazan Y, Abad-Licham M, Mengoa C, Fuentes H, Montenegro P, Poquioma E, Alatrista R, Flores CJ, Taxa L. Association between Helicobacter pylori infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancer. World J Gastrointest Oncol 2024; 16(6): 2487-2503
- URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2487.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2487